Stablepharma announce Phase 1 clinical trial results for SPVX02, a thermostable reformulation of a licensed Td vaccine, published in the eClinicalMedicine These findings strengthen the scientific and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results